Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European

Ryan E Aylward1,2, Samantha Hayward3,4, Nicholas C Chesnaye5,6

  • 1Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

PubMed

Insights

This study links higher levels of specific proteins, including Receptor-type tyrosine-protein phosphatase S, to faster kidney function decline in older adults with advanced chronic kidney disease (CKD). These findings highlight fibrogenesis and complement pathways in CKD progression.

Area of Science:

  • Proteomics
  • Nephrology
  • Cardiovascular Medicine

Background:

  • Cardiovascular disease (CVD) and chronic kidney disease (CKD) share similar pathophysiological mechanisms.
  • Investigating protein expression in advanced CKD can elucidate kidney function decline.
  • Older adults with advanced CKD present a critical population for understanding disease progression.

Purpose of the Study:

  • To investigate the associations between cardiometabolic protein expression and pathways with kidney function decline.
  • To explore the mechanisms underlying CKD progression in older adults.
  • To identify specific proteins and pathways linked to the rate of estimated glomerular filtration rate (eGFR) decline.

Main Methods:

  • Utilized plasma proteomic panels (Olink cardiometabolic T96 and cardiovascular II T96) from the European Quality (EQUAL) Study.
  • Analyzed longitudinal estimated glomerular filtration rate (eGFR) data from European adults aged over 65 with advanced CKD (eGFR <20 mL/min/1.73 m²).
  • Employed generalized linear mixed-effects models to estimate protein-slope associations and pathway enrichment analysis for biological pathways.

Main Results:

  • Higher expression of Receptor-type tyrosine-protein phosphatase S, Insulin-like growth factor binding protein 6, and Ficolin 2 were significantly associated with accelerated eGFR decline.
  • A doubling of Receptor-type tyrosine-protein phosphatase S expression correlated with a -15.4% annual change in eGFR.
  • Validated associations were found between specific proteins and the rate of kidney function loss across discovery and validation cohorts.

Conclusions:

  • Elevated protein expression and pathways related to fibrogenesis and the complement cascade are associated with kidney function loss in advanced CKD.
  • These findings suggest potential therapeutic targets for slowing CKD progression.
  • Further research is needed to validate these findings and explore kidney cellular proteomic signatures.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
35
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
571
Kidney Structure01:45

Kidney Structure

The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
66.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K